CLGN - CIK 0001631487
No parsed quarterly data available for CollPlant Biotechnologies Ltd yet.
CollPlant Biotechnologies Ltd reported operating cash flow of -$9.42M for fiscal year 2025. That is up 33.2% from -$14.09M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow declined from -$1.22M (FY 2018) to -$9.42M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.